Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity

Clinical trial NCT00580060 · COMPLETED

Trial details

NCT number

NCT00580060

Sponsor

Memorial Sloan Kettering Cancer Center

Status

COMPLETED

Phase

Early Phase 1

Study type

INTERVENTIONAL

Start date

2003-12-01

Primary completion

2011-06-01

Enrollment

20

View on ClinicalTrials.gov